Achieve Life Sciences' cytisinicline beats Pfizer's varenicline in smoking cessation study [Seeking Alpha]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Seeking Alpha
Healthcare|On the MoveAchieve Life Sciences' cytisinicline beats Pfizer's varenicline in smoking cessation studySep. 18, 2020 10:01 AM ETAchieve Life Sciences, Inc. (ACHV)Vandana SinghAchieve Life Sciences (+18.0%announced presentationThe primary endpoint was that cytisinicline quit rates would be no less than 10% lower than the quit rates for varenicline, and the study demonstrated a 4.29% improvement in quit rates in favor of cytisinicline.Continuous abstinence rates at 6 months, verified by exhaled carbon monoxide, were 12.1% for cytisinicline compared to 7.9% for varenicline.Subjects in the cytisinicline arm were ~1.5x more likely to have quit smoking at 6 months compared to subjects in varenicline arm.Additionally, significantly fewer overall adverse events were reported in cytisinicline-treated subjects. The safety profile in RAUORA confirms that cytisinicline continues todemonstrate lower AEs, in particular, reduced nauseaSubjects who experienced adverse events (111 in the cyti
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Morningstar unveils 10 cheap stocks with big moats [Yahoo! Finance]Yahoo! Finance
- Cramer's Lightning Round: Leidos is a winner [CNBC]CNBC
- United States Frontotemporal Dementia Market to Experience Steady Growth Through 2028 [Yahoo! Finance]Yahoo! Finance
- Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Pfizer, Astellas first-line bladder cancer therapy accepted for review in China [Seeking Alpha]Seeking Alpha
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 3/28/24 - Form DEFA14A
- 3/28/24 - Form DEFA14A
- 3/18/24 - Form 4
- PFE's page on the SEC website